Theseus Pharmaceuticals(NASDAQ:THRX) 
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-variant inhibitor for activating and resistance mutations of the KIT kinas...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-08-17
P
O 2.96
H 2.97
L 2.82
C 2.85
V 218,554
10EMA 2.85
20EMA 2.85
60EMA 2.85
120EMA 2.85
250EMA 2.85